Biosafety and Bioethics in Biotechnology
Policy, Advocacy, and Capacity Building
Sylvia Uzochukwu, Nwadiuto (Diuto) Esiobu, Arinze Stanley Okoli, Emeka Godfrey Nwoba, Ezebuiro Nwagbo Christpeace, Charles Oluwaseun Adetunji, Abdulrazak B. Ibrahim, Benjamin Ewa Ubi, Sylvia Uzochukwu, Nwadiuto (Diuto) Esiobu, Arinze Stanley Okoli, Emeka Godfrey Nwoba, Ezebuiro Nwagbo Christpeace, Charles Oluwaseun Adetunji, Abdulrazak B. Ibrahim, Benjamin Ewa Ubi
- 212 pages
- English
- ePUB (mobile friendly)
- Available on iOS & Android
Biosafety and Bioethics in Biotechnology
Policy, Advocacy, and Capacity Building
Sylvia Uzochukwu, Nwadiuto (Diuto) Esiobu, Arinze Stanley Okoli, Emeka Godfrey Nwoba, Ezebuiro Nwagbo Christpeace, Charles Oluwaseun Adetunji, Abdulrazak B. Ibrahim, Benjamin Ewa Ubi, Sylvia Uzochukwu, Nwadiuto (Diuto) Esiobu, Arinze Stanley Okoli, Emeka Godfrey Nwoba, Ezebuiro Nwagbo Christpeace, Charles Oluwaseun Adetunji, Abdulrazak B. Ibrahim, Benjamin Ewa Ubi
About This Book
This book covers a range of important topics in biotechnology policy, advocacy and education, bioethics, biosafety regulations for genetically modified organisms and gene-edited products and biotechnology manpower development. Throughout the book, the contributors review biosafety and bioethical guidelines that could enhance adoption of biotechnology in alignment with national priorities and research agendas. They also discuss the importance of current biotechnology policy advocacy, enlightenment and public engagement with stakeholders and policy makers. The book will be useful reference material for scientists and researchers working in the fields of food and agricultural biotechnology, biopharmaceuticals and medical biotechnology, environmental biotechnology, biotechnology policy and advocacy, biotechnology communication and manpower development, biosafety and bioethics, etc.
-
- Emphasizes recent advances in biotechnology that could ameliorate the high-level global food insecurity through the deployment of the technology in Nigeria
-
- Provides detailed information on how to domesticate biotechnology and boost training of the biotechnology workforce in the universities and research institutes
-
- Introduces new frontiers in the area of organizing informal biotechnology capacity building courses and professional certification
-
- Reviews biosafety and bioethical guidelines that could enhance adoption of biotechnology in alignment with national priorities and research agendas
-
- Discusses current biotechnology policy advocacy, enlightenment and public engagement with stakeholders and policy makers
Sylvia Uzochukwu, Ph.D., is a Professor of Food Science and Biotechnology, and Director, Biotechnology Centre, Federal University, Oye-Ekiti, Nigeria.
Arinze Stanley Okoli, Ph.D., is an Associate Professor at Genoek – Centre for Biosafety, Universitetet II, Breivika, Tromsoe, Norway.
Nwadiuto (Diuoto) Esiobu, Ph.D., is a Professor of Microbiology and Biotechnology at Florida Atlantic University, Boca Raton, FL, USA, and the President and Founder of Applied Biotech, Inc. and ABINL.
Emeka Godfrey Nwoba, Ph.D., is currently at the Algae Research & Development Centre, Murdoch University, Western Australia.
Christpeace Nwagbo Ezebuiro, Ph.D., is a Project Manager, Renewable Energy Expert and Head of Clean Technology Division at the National Biotechnology Development Agency, Abuja, Nigeria.
Charles Oluwaseun Adetunji, Ph.D., is an Associate Professor of Microbiology and Biotechnology and the Director of Intellectual Property and Technology Transfer, Edo State University Uzairue, Nigeria.
Abdulrazak B. Ibrahim, Ph.D., is a Capacity Development Expert at the Forum for Agricultural Research in Africa (FARA) and Associate Professor of Biochemistry, Ahmadu Bello University, Zaria, Nigeria.
Benjamin Ewa Ubi, Ph.D., is a Professor of Plant Breeding and Biotechnology and Director, Biotechnology Research and Development Centre, Ebonyi State University Abakaliki, Nigeria.
Frequently asked questions
Information
1 Status of Nigeria’s Biosafety Regulation
CONTENTS
- 1.1 Introduction
- 1.1.1 Mandate, Vision and Mission
- 1.1.2 Problem Statement and Justification
- 1.2 Evolution of Biosafety Regulation in Nigeria
- 1.3 Essentials of the Nigerian Biosafety System
- 1.3.1 Risk Analysis
- 1.3.2 Nigeria’s Biosafety Regulatory Instruments
- 1.3.2.1 National Biosafety Management Act 2015
- 1.3.2.2 National Biosafety Regulation 2018
- 1.3.2.3 National Biosafety Policy 2018
- 1.3.2.4 National Biosafety Risk Analysis Framework 2018
- 1.3.2.5 Biosafety Guidelines
- 1.3.2.6 Biosafety Manuals
- 1.3.3 National Genetic Modification, Detection and Analysis Laboratory
- 1.4 Goals of the Nigeria Biosafety System
- 1.5 Nigeria’s Biosafety Decisions So Far
- 1.5.1 Accreditation of Institutes to Carry Out Modern Biotechnology Activities
- 1.5.2 Approval for Confined Field Trials in Nigeria
- 1.5.3 Approval for Commercial Release
- 1.5.4 Approval for Food, Feed and/or Processing (FFP)
- 1.5.5 Gene Registration
- 1.6 Synergy among Stakeholders for Effective Regulation of Modern Biotechnology and GMOs in Nigeria
- 1.6.1 Collaborating Organizations in Nigeria with NBMA
- 1.6.1.1 Foreign/Developmental Partners
- 1.6.1.2 Ministries, Department and Agencies
- 1.6.1.3 National Research Institutes
- 1.6.1.4 Non-Governmental Organizations (NGOs), Civil Society Organizations (CSOs), Professional Organizations, Faith-Based Organizations (FBOs) and Community-Based Organizations (CBOs)
- 1.6.1.5 Media
- 1.6.2 Memorandum of Understanding (MoU) with Relevant Regulatory Agencies
- 1.6.1 Collaborating Organizations in Nigeria with NBMA
- 1.7 The Role of Nigeria in International Biosafety Regulation
- 1.8 New Focus
- 1.9 Regulatory Challenges
- 1.10 Conclusion
- References
1.1 Introduction
1.1.1 Mandate, Vision and Mission
- Mandate: Provision of regulatory framework, institutional and administrative mechanisms for safety measures in the application of modern biotechnology in Nigeria with a view to preventing any adverse effects on human health, animals and the environment.
- Vision: Having in place a holistic, responsive and vibrant National Biosafety System that offers the best of its potentials in the regulation of modern biotechnology activities in Nigeria, with a view to preventing any adverse impact on the conservation and sustainability of biodiversity taking into account risk to human health.
- Mission: To promote the basic tenets of biosafety as enunciated in the Cartagena Protocol on Biosafety and enforce Nigeria National Biosafety Management Agency Act 2015, regulations and guidelines to ensure safe application and use of products of modern biotechnology.
- Core values: The Agency, as the Competent National Authority on Biosafety issues, operates on the following core values: safety to the environment and human health, respect for human dignity, transparency, integrity and professionalism.
- Enabling authority: Established by the National Biosafety Management Agency Act 2015, to provide regulatory framework to adequately safeguard human health and the environment from potential adverse effects, while harnessing the potentials of modern biotechnology and its derivatives, for the benefit of Nigeria.
1.1.2 Problem Statement and Justification
- To state the various biosafety regulatory instruments developed;
- To give an outline of the biosafety decisions reached;
- To outline the challenges faced by the Agency in the discharge of her duties.
1.2 Evolution of Biosafety Regulation in Nigeria
Regulation Stages | Dates |
---|---|
First National Biosafety Guidelines, under Federal Ministry of Agriculture and Natural Resources | 1994 |
Biodiversity/Biosafety activities under the defunct Federal Environmental Protection Agency (FEPA) | 1997 |
National Biosafety Unit, Federal Ministry of Environment | 1999 |
Second National Biosafety Guidelines, under Federal Ministry of Environment (FMEnv) | 2001 |
Nigeria signed and ratified the Cartagena Protocol on Biosafety | 2000, 2003 |
Development of National Biosafety Framework (NBF) | 2002–2006 |
Development of National Biosafety Policy | 2002–2006 |
Draft Biosafety Bill, among others | 2002–2006 |
N... |